MARKET

AMAG

AMAG

AMAG
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.94
-0.62
-9.45%
After Hours: 5.94 0 0.00% 16:56 03/27 EDT
OPEN
6.42
PREV CLOSE
6.56
HIGH
6.44
LOW
5.92
VOLUME
471.18K
TURNOVER
--
52 WEEK HIGH
13.53
52 WEEK LOW
4.410
MARKET CAP
203.54M
P/E (TTM)
-0.4335
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AMAG and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AMAG stock price target is 9.44 with a high estimate of 12.00 and a low estimate of 6.00.

EPS

AMAG News

More
  • AMAG Pharmaceuticals (AMAG) Moves to Buy: Rationale Behind the Upgrade
  • Zacks · 4d ago
  • AMAG Pharmaceuticals (AMAG) Presents At Barclays Global Healthcare Conference - Slideshow
  • Seeking Alpha - Article · 03/13 18:31
  • Edited Transcript of AMAG earnings conference call or presentation 4-Mar-20 1:00pm GMT
  • Thomson Reuters StreetEvents · 03/13 03:33
  • The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
  • Benzinga · 03/12 11:37

Industry

Pharmaceuticals
-0.41%
Pharmaceuticals & Medical Research
-0.87%

Hot Stocks

Symbol
Price
%Change

About AMAG

AMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia management and cancer supportive care, including its product, Makena (hydroxyprogesterone caproate injection); its product, Feraheme (ferumoxytol), for intravenous (IV) use, and MuGard Mucoadhesive Oral Wound Rinse. It is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women. Makena is a drug indicated to reduce the risk of preterm birth in women pregnant with a single baby having a history of singleton spontaneous preterm birth.
More

Webull offers kinds of AMAG Pharmaceuticals, Inc. stock information, including NASDAQ:AMAG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMAG stock news, and many more online research tools to help you make informed decisions.